Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Eli Lilly receives breakthrough status for baricitinib in alopecia

pharmaceutical-technologyMarch 18, 2020

Tag: Eli Lilly , Baricitinib , Alopecia

PharmaSources Customer Service